Annual Meeting 2006: The biotechnology and pharmaceutical industry faces a unique and daunting set of statutory and regulatory issues, including, but not limited to, the handling and disposal of radioactive materials, employee health & safety procedures involving unique and exotic compounds, NRC licensing, and good laboratory practices. Smaller companies in this industry also face unique challenges such as developing sound EH&S programs in-house as well as negotiating leases with landlords unfamiliar with biotech research operations.